Arno Therapeutics To Present At 26th Annual ROTH Conference

Published: Mar 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that Chief Executive Officer Glenn Mattes is scheduled to present at the 26th Annual ROTH Conference, being held March 9-12, 2014 at the Ritz-Carlton, Laguna Niguel in Dana Point, CA.

Help employers find you! Check out all the jobs and post your resume.

Back to news